Mandate

Vinge advises TA Associates together with Goodwin Procter in connection with acquisition

August 23, 2023 M&A

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

TA is a leading global private equity firm focused on scaling growth in profitable companies. Warburg Pincus is a leading global growth investor and an experienced partner to management teams seeking to build durable companies with sustainable value. Epassi Group is Europe’s leading digital solution for employee benefits, with a reach of nearly 13 million users, over 13 500 employers, and more than 59 000 service providers. Epassi is a market leader in the provision of digital employee benefits within the Nordics, Italy and the UK and has been awarded by the Financial Times as one of the fastest growing companies in Europe in 2022 and 2023.

Vinge's team consisted mainly of Sofie Nordgren, Niklas Törnell and Emil Sandgrim.

Full pressrelease 

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025